Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine.
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
DNA containing 5-azacytosine (azaC) has previously been shown to be a potent inhibitor of DNA-cytosine methyltransferases. In this report, we describe experiments which demonstrate that azaC-DNA forms a covalent complex with Hpa II methylase, a bacterial enzyme that methylates the internal C of C-C-G-G sequences. The complex does not undergo detectable dissociation over at least 3 days and is stable to denaturation with NaDodSO4. After extensive digestion of the complex with DNase and phosphodiesterase, gel filtration gave the methylase bound to approximately one equivalent of azaC; the digested complex had an apparent molecular weight similar to that of the native enzyme. Although prior treatment of azaC-DNA with Hpa II endonuclease had only a slight effect on binding of the methylase, treatment with Msp I endonuclease, which also cleaves at C-C-G-G sequences, resulted in a significant reduction in binding; this indicates that azaC residues in the recognition sequence of Hpa II are an important component in the covalent interaction of the methylase. However, since there was residual binding it is possible that azaC residues elsewhere in DNA also covalently bind to the methylase. These results provide an explanation of why azaC-DNA is such a potent inhibitor of cytosine methyltransferases and how the incorporation of such low levels of azaC into DNA can result in dramatic decreases in the methylation of cytosine. Finally, consideration of the probable catalytic mechanism of cytosine methylases and the chemical properties of azaC suggests that the inhibition is, at least in part, an active-site directed process and permits a proposal for the structure of the covalent complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA Methylation and Gene Function
Razin, A., & Riggs, A. D. (1980) · Science · doi:10.1126/science.6254144 · Cited by 2,071
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
DNA METHYLATION AND GENE ACTIVITY
Doerfler, W. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.000521 · Cited by 1,098
Creusot, F., Acs, G., & Christman, J. K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68144-5 · Cited by 564
DNA methylation controls the inducibility of the mouse metallothionein-I gene in lymphoid cells
Compere, S. J., & Palmiter, R. D. (1981) · Cell · doi:10.1016/0092-8674(81)90248-8 · Cited by 465
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs
Santi, D. V., Garrett, C. E., & Barr, P. J. (1983) · Cell · doi:10.1016/0092-8674(83)90327-6 · Cited by 401
Self-citationBinding of Large Organic Anions and Neutral Molecules by Native Bovine Serum Albumin*
Ray, A., Reynolds, J. A., Polet, H., & Steinhardt, J. (1966) · Biochemistry · doi:10.1021/bi00872a019 · Cited by 217
Mechanism of action of eukaryotic DNA methyltransferase
Taylor, S. M., & Jones, P. A. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90395-3 · Cited by 201
Induction of thymidine kinase in enzyme-deficient chinese hamster cells
Harris, M. (1982) · Cell · doi:10.1016/0092-8674(82)90165-9 · Cited by 195
High-pressure liquid chromatography-ultraviolet analysis of intracellular nucleotides
Pogolotti, A. L., & Santi, D. V. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90524-3 · Cited by 157
Self-citation
Cited by
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
The Inheritance of Epigenetic Defects
Holliday, R. (1987) · Science · doi:10.1126/science.3310230 · Cited by 1,082
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
DNA methylation: a historical perspective
Mattei, A. L., Bailly, N., & Meissner, A. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.03.010 · Cited by 861
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Jüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Tsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
Beyond Watson and Crick: DNA Methylation and Molecular Enzymology of DNA Methyltransferases
Jeltsch, A. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020402)3:4<274::aid-cbic274>3.0.co;2-s · Cited by 610
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Biochemistry and biology of mammalian DNA methyltransferases
Hermann, A., Gowher, H., & Jeltsch, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4201-1 · Cited by 537
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
AdoMet-dependent methylation, DNA methyltransferases and base flipping
Cheng, X. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3784 · Cited by 485
CpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedDNA methylation and the regulation of gene transcription
Attwood, J. T., Yung, R. L., & Richardson, B. C. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8420-z · Cited by 429
Kinetic and catalytic mechanism of HhaI methyltransferase.
Wu, J. C., & Santi, D. V. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61263-3 · Cited by 420
Self-citationDNA methylation and genetic instability in colorectal cancer cells
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2545 · Cited by 396
Momparler, R. L., & Bovenzi, V. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2<145::aid-jcp1>3.0.co;2-v · Cited by 387
Alterations of immune response of non-small cell lung cancer with Azacytidine
Wrangle, J., Wang, W., Koch, A., Easwaran, H., Mohammad, H. P., Pan, X., Vendetti, F., VanCriekinge, W., DeMeyer, T., Du, Z., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1542 · Cited by 386
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Palii, S. S., Van Emburgh, B. O., Sankpal, U. T., Brown, K. D., & Robertson, K. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01799-07 · Cited by 382
Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., & Hornby, D. P. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00676-9 · Cited by 362
The future of epigenetic therapy in solid tumours—lessons from the past
Azad, N., Zahnow, C. A., Rudin, C. M., & Baylin, S. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.42 · Cited by 335
Use of Epigenetic Drugs in Disease: An Overview
Heerboth, S., Lapinska, K., Snyder, N., Leary, M., Rollinson, S., & Sarkar, S. (2014) · Genetics & Epigenetics · doi:10.4137/geg.s12270 · Cited by 326
Preferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells
Estève, P.-O., Chin, H. G., Benner, J., Feehery, G. R., Samaranayake, M., Horwitz, G. A., Jacobsen, S. E., & Pradhan, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810362106 · Cited by 318
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
Bhalla, K. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.600 · Cited by 308
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells
Gojo, S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00132-0 · Cited by 255
Molecular Enzymology of Mammalian DNA Methyltransferases
Jeltsch, A. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31390-7_7 · Cited by 200
Dees, C., Schlottmann, I., Funke, R., Distler, A., Palumbo-Zerr, K., Zerr, P., Lin, N.-Y., Beyer, C., Distler, O., Schett, G., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203194 · Cited by 199
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., et al. (2011) · The Prostate · doi:10.1002/pros.21247 · Cited by 194
“These nucleoside analogs are incorporated in the DNA during S-phase and inhibit DNMT by irreversibly trapping the enzyme to DNA [17,40].”
BackgroundNSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs
Haag, S., Warda, A. S., Kretschmer, J., Günnigmann, M. A., Höbartner, C., & Bohnsack, M. T. (2015) · RNA · doi:10.1261/rna.051524.115 · Cited by 188
“1536 RNA, Vol. 21, No. 9 peptide in motif IV for covalent complex formation during the methylation reaction (Santi et al. 1984; Wu and Santi 1987; King and Redman 2002).”
BackgroundEffects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
Billam, M., Sobolewski, M. D., & Davidson, N. E. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0420-3 · Cited by 158
DNA methylation regulates neuronal glutamatergic synaptic scaling
Meadows, J. P., Guzman-Karlsson, M. C., Phillips, S., Holleman, C., Posey, J. L., Day, J. J., Hablitz, J. J., & Sweatt, J. D. (2015) · Science Signaling · doi:10.1126/scisignal.aab0715 · Cited by 111
Guilleret, I., & Benhattar, J. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00281-7 · Cited by 110
Natsume, A., Wakabayashi, T., Tsujimura, K., Shimato, S., Ito, M., Kuzushima, K., Kondo, Y., Sekido, Y., Kawatsura, H., Narita, Y., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23407 · Cited by 93
Digging deep into “dirty” drugs – modulation of the methylation machinery
Pleyer, L., & Greil, R. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.995379 · Cited by 84
“The commonly accepted mechanism of action of HMAs is based on the initial report that incorporation of these structurally similar cytosine analogues into DNA inhibits the capacity of DNMTs to methylate DNA (Santi et al., 1984).”
BackgroundScott, H., Smith, A. E., Barker, G. R., Uney, J. B., & Warburton, E. C. (2017) · Neuroepigenetics · doi:10.1016/j.nepig.2017.02.001 · Cited by 18
“…inhibitor 5AZA is a cytosine analogue that blocks DNMT function by covalently binding to the enzyme's catalytic cysteine residue (Santi et al., 1983, Santi et al., 1984) and may require incorporation into the DNA strand to exert its inhibitory effect (Creusot et al., 1982; Stresemann et al., 2006).”
Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells
Nakamura, K., Aizawa, K., Aung, K. H., Yamauchi, J., & Tanoue, A. (2017) · Scientific Reports · doi:10.1038/srep41093 · Cited by 16
Metadata
- Authors
- Santi, D. V., Norment, A., & Garrett, C. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1984-11
- Volume
- 81
- Issue
- 22
- Pages
- 6993-6997
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2002788005
- Cited by
- 518
- References
- 16
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.